UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age - PubMed (original) (raw)
. 2015 Mar 31;12(3):e1001779.
doi: 10.1371/journal.pmed.1001779. eCollection 2015 Mar.
John Gallacher 2, Naomi Allen 3, Valerie Beral 4, Paul Burton 5, John Danesh 6, Paul Downey 7, Paul Elliott 7, Jane Green 4, Martin Landray 4, Bette Liu 8, Paul Matthews 7, Giok Ong 9, Jill Pell 10, Alan Silman 11, Alan Young 4, Tim Sprosen 4, Tim Peakman 12, Rory Collins 3
Affiliations
- PMID: 25826379
- PMCID: PMC4380465
- DOI: 10.1371/journal.pmed.1001779
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age
Cathie Sudlow et al. PLoS Med. 2015.
Abstract
Cathie Sudlow and colleagues describe the UK Biobank, a large population-based prospective study, established to allow investigation of the genetic and non-genetic determinants of the diseases of middle and old age.
Conflict of interest statement
All authors are current or past members of UK Biobank’s executive management team or steering committee, or of one of UK Biobank’s working groups. PM is a part-time employee and holder of stock and options in GlaxoSmithKline and has received attendance fees and contributed to panels convened by the Medical Research Council, a public funder of UK Biobank. JD has received research funding from The Wellcome Trust, British Heart Foundation, UK Medical Research Council, BUPA Foundation, Denka, diaDexus, European Research Council, European Union, Evelyn Trust, Fogarty International Centre, GlaxoSmithKline, Merck, National Heart, Lung and Blood Institute, National Health Service Blood and Transplant, National Institute for Health Research, National Institute of Neurological Disorders and Stroke, Novartis, Pfizer, Roche, UK Biobank. RC is the CEO and PI of UK Biobank, which is a charity set up by the MRC and Wellcome Trust to establish this prospective cohort as a resource for researchers from around the world. RC is a member of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.
Similar articles
- Genetics, lifestyle and environment. UK Biobank is an open access resource following the lives of 500,000 participants to improve the health of future generations.
Trehearne A. Trehearne A. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Mar;59(3):361-7. doi: 10.1007/s00103-015-2297-0. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016. PMID: 26753864 - The advantages of UK Biobank's open-access strategy for health research.
Conroy M, Sellors J, Effingham M, Littlejohns TJ, Boultwood C, Gillions L, Sudlow CLM, Collins R, Allen NE. Conroy M, et al. J Intern Med. 2019 Oct;286(4):389-397. doi: 10.1111/joim.12955. Epub 2019 Aug 2. J Intern Med. 2019. PMID: 31283063 Free PMC article. - UK Biobank: a globally important resource for cancer research.
Conroy MC, Lacey B, Bešević J, Omiyale W, Feng Q, Effingham M, Sellers J, Sheard S, Pancholi M, Gregory G, Busby J, Collins R, Allen NE. Conroy MC, et al. Br J Cancer. 2023 Feb;128(4):519-527. doi: 10.1038/s41416-022-02053-5. Epub 2022 Nov 19. Br J Cancer. 2023. PMID: 36402876 Free PMC article. Review. - New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders.
Bešević J, Lacey B, Conroy M, Omiyale W, Feng Q, Collins R, Allen N. Bešević J, et al. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2403-2410. doi: 10.1210/clinem/dgac407. J Clin Endocrinol Metab. 2022. PMID: 35793237 Free PMC article. - Prospective study design and data analysis in UK Biobank.
Allen NE, Lacey B, Lawlor DA, Pell JP, Gallacher J, Smeeth L, Elliott P, Matthews PM, Lyons RA, Whetton AD, Lucassen A, Hurles ME, Chapman M, Roddam AW, Fitzpatrick NK, Hansell AL, Hardy R, Marioni RE, O'Donnell VB, Williams J, Lindgren CM, Effingham M, Sellors J, Danesh J, Collins R. Allen NE, et al. Sci Transl Med. 2024 Jan 10;16(729):eadf4428. doi: 10.1126/scitranslmed.adf4428. Epub 2024 Jan 10. Sci Transl Med. 2024. PMID: 38198570 Free PMC article. Review.
Cited by
- HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study.
Rong ZX, Wei W, Zeng Q, Cai XT, Wang YY, Wang J, Luo HS, Xiao LS, Lin JR, Bai X, Zhang YP, Han DD, Dong ZY, Wang W, Wu DH, Ma SC. Rong ZX, et al. BMC Med. 2024 Oct 8;22(1):443. doi: 10.1186/s12916-024-03676-6. BMC Med. 2024. PMID: 39380026 - Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes.
Huerta-Chagoya A, Schroeder P, Mandla R, Li J, Morris L, Vora M, Alkanaq A, Nagy D, Szczerbinski L, Madsen JGS, Bonàs-Guarch S, Mollandin F, Cole JB, Porneala B, Westerman K, Li JH, Pollin TI, Florez JC, Gloyn AL, Carey DJ, Cebola I, Mirshahi UL, Manning AK, Leong A, Udler M, Mercader JM. Huerta-Chagoya A, et al. Nat Genet. 2024 Oct 8. doi: 10.1038/s41588-024-01947-9. Online ahead of print. Nat Genet. 2024. PMID: 39379762 - Disease coverage of human genome-wide association studies and pharmaceutical research and development.
Gordillo-Marañón M, Schmidt AF, Warwick A, Tomlinson C, Ytsma C, Engmann J, Torralbo A, Maclean R, Sofat R, Langenberg C, Shah AD, Denaxas S, Pirmohamed M, Hemingway H, Hingorani AD, Finan C. Gordillo-Marañón M, et al. Commun Med (Lond). 2024 Oct 8;4(1):195. doi: 10.1038/s43856-024-00625-5. Commun Med (Lond). 2024. PMID: 39379679 - The levels of amino acid metabolites in serum induce the pathogenesis of atopic dermatitis by mediating the inflammatory protein S100A12.
Zhang Y, Xu H, Tang Y, Li Y, Zheng F. Zhang Y, et al. Sci Rep. 2024 Oct 8;14(1):23435. doi: 10.1038/s41598-024-74522-1. Sci Rep. 2024. PMID: 39379513 - Causal impacts of smoking on pain conditions and the mediating pathways: a mendelian randomization study.
Zhang K, Liang H. Zhang K, et al. Sci Rep. 2024 Oct 8;14(1):23375. doi: 10.1038/s41598-024-75393-2. Sci Rep. 2024. PMID: 39379490
References
- Clayton D, McKeigue PM (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358: 1356–1360. - PubMed
- Willett WC, Blot WJ, Colditz GA, Folsom AR, Henderson BE, Stampfer MJ (2007). Merging and emerging cohorts: not worth the wait. Nature 445: 257–258. - PubMed
- Collins FS, Manolio TA (2007). Merging and emerging cohorts: necessary but not sufficient. Nature 445: 259 - PubMed
- Doll R, Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute 66: 1191–1308. - PubMed
- Ollier W, Sprosen T, Peakman T (2005). UK Biobank: from concept to reality. Pharmacogenomics 6: 639–646. - PubMed
Publication types
MeSH terms
Grants and funding
- SP/13/2/30111/BHF_/British Heart Foundation/United Kingdom
- MR/L003120/1/MRC_/Medical Research Council/United Kingdom
- 093707/WT_/Wellcome Trust/United Kingdom
- DH_/Department of Health/United Kingdom
- MR/L01341X/1/MRC_/Medical Research Council/United Kingdom
- MR/K006525/1/MRC_/Medical Research Council/United Kingdom
- MR/K007017/1/MRC_/Medical Research Council/United Kingdom
- RG/08/014/24067/BHF_/British Heart Foundation/United Kingdom
- 16491/CRUK_/Cancer Research UK/United Kingdom
- MR/K02700X/1/MRC_/Medical Research Council/United Kingdom
- MC_U137686860/MRC_/Medical Research Council/United Kingdom
- MR/L016265/1/MRC_/Medical Research Council/United Kingdom
- CSO_/Chief Scientist Office/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources